Immunovant Stock Price on January 4, 2024
| IMVT Stock | USD 28.20 0.53 1.84% |
Below is the normalized historical share price chart for Immunovant extending back to June 21, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunovant stands at 28.20, as last reported on the 30th of November, with the highest price reaching 28.98 and the lowest price hitting 28.00 during the day.
If you're considering investing in Immunovant Stock, it is important to understand the factors that can impact its price. Immunovant holds Efficiency (Sharpe) Ratio of -0.0283, which attests that the entity had a -0.0283% return per unit of risk over the last 3 months. Immunovant exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunovant's Market Risk Adjusted Performance of (0.12), risk adjusted performance of (0.03), and Standard Deviation of 2.82 to validate the risk estimate we provide.
At this time, Immunovant's Total Stockholder Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 1.5 B in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 386.8 M in 2024. . At this time, Immunovant's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 3,193 in 2024, despite the fact that Price To Free Cash Flows Ratio is likely to grow to (5.00). Immunovant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of June 2019 | 200 Day MA 29.7619 | 50 Day MA 28.9884 | Beta 0.709 |
Immunovant |
Sharpe Ratio = -0.0283
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMVT |
Estimated Market Risk
| 2.88 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immunovant is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunovant by adding Immunovant to a well-diversified portfolio.
Price Book 9.2179 | Book Value 3.064 | Enterprise Value 3.7 B | Enterprise Value Ebitda (14.12) | Shares Float 65.7 M |
Related Headline
Protagonist Therapeutics Headline on 4th of January 2024
Acquisition by Dinesh Patel of 84875 shares of Protagonist T... by Dinesh Patel
Filed transaction by Protagonist Therapeutics director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Immunovant Valuation on January 4, 2024
It is possible to determine the worth of Immunovant on a given historical date. On January 4, 2024 Immunovant was worth 38.85 at the beginning of the trading date compared to the closed value of 38.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunovant stock. Still, in general, we apply an absolute valuation method to find Immunovant's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunovant where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunovant's related companies.
| Open | High | Low | Close | Volume | |
| 40.55 | 40.81 | 38.47 | 38.77 | 1,736,600 | |
01/04/2024 | 38.85 | 39.13 | 37.71 | 38.89 | 2,106,000 |
| 38.59 | 43.47 | 38.59 | 42.78 | 2,949,700 |
| Backtest Immunovant | | | Immunovant History | | | Immunovant Valuation | Previous | Next |
Immunovant Trading Date Momentum on January 4, 2024
| On January 05 2024 Immunovant was traded for 42.78 at the closing time. The top price for the day was 43.47 and the lowest listed price was 38.59 . The trading volume for the day was 2.9 M. The trading history from January 5, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 10.00% . The trading delta at closing time against the current closing price is 8.18% . |
Immunovant Fundamentals Correlations and Trends
By evaluating Immunovant's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunovant's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunovant financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunovant Stock history
Immunovant investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunovant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunovant will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunovant stock prices may prove useful in developing a viable investing in Immunovant
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 138.1 M | 80.8 M | |
| Net Loss | (450.00) | (472.50) |
Immunovant Quarterly Net Working Capital |
|
Immunovant Stock Technical Analysis
Immunovant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunovant Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Immunovant cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immunovant November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunovant stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunovant shares will generate the highest return on investment. By undertsting and applying Immunovant stock market strength indicators, traders can identify Immunovant entry and exit signals to maximize returns
Immunovant Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunovant's price direction in advance. Along with the technical and fundamental analysis of Immunovant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunovant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Immunovant Stock Analysis
When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.